Back to funds
View filing
Fairmount Funds Management LLC
Updated 6 days agoManaged by Fairmount Funds Management Llc • Latest filing Q3 2026
Portfolio value
$1.6B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $1.3B |
| Q1 2026 | $1.4B |
| Q2 2026 | $1.5B |
| Q3 2026 | $1.6B |
Top holdings
12 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $308.6M | 3.71M | 19.35% | — | |
| 2 | $291.3M | 9.10M | 18.27% | — | |
| 3 | $223.4M | 2.54M | 14.01% | — | |
| 4 | ? N/A DAMORA THERAPEUTICS INC | $185.4M | 8.71M | 11.63% | — |
| 5 | $176.2M | 5.50M | 11.05% | — | |
| 6 | $104.8M | 5.09M | 6.57% | — | |
| 7 | $85.1M | 1.86M | 5.33% | — | |
| 8 | $64M | 4.55M | 4.01% | — | |
| 9 | $64M | 2.37M | 4.01% | — | |
| 10 | $52.5M | 3.60M | 3.30% | — | |
| 11 | $21.5M | 722.0K | 1.35% | — | |
| 12 | $17.7M | 8.63M | 1.11% | — |